Creaven P J, Madajewicz S, Mittelman A
Urol Clin North Am. 1984 May;11(2):343-56.
The authors consider treatments that are applicable to disseminated prostatic cancer. Several types of potential developments in systemic therapy for prostatic cancer are considered: new hormonal agents, new cytotoxic agents, modulation of the antitumor efficacy or toxicity or both of standard agents, biologic response modifiers, drug delivery systems, and systems for prediction of response.
作者们考虑了适用于播散性前列腺癌的治疗方法。文中探讨了前列腺癌全身治疗中几种潜在的发展方向:新型激素药物、新型细胞毒性药物、调节标准药物的抗肿瘤疗效或毒性或两者、生物反应调节剂、药物递送系统以及反应预测系统。